Q/C Technologies, Inc. (QCLS) Scorecard
- 2026-Q2: Total return Lose; Revenue growth No data; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth No data; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth No data; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth No data; EPS growth Lose.
16/66
1.2 / 5 stars
All 66 Win/Lose results and 54 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 0 wins, 8 losses, 4 no dataLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/2 |
LoseQCLS / S&P 13.04% / 15.20% |
No dataQCLS / S&P / 15.00% |
LoseQCLS / S&P -101.17% / 50.40% |
| 2026-Q10/2 |
LoseQCLS / S&P -13.53% / -4.33% |
No dataQCLS / S&P / 11.30% |
LoseQCLS / S&P -73.25% / 27.70% |
| 2025-Q40/2 |
LoseQCLS / S&P -3.86% / 2.65% |
No dataQCLS / S&P / 9.00% |
LoseQCLS / S&P -73.85% / 13.40% |
| 2025-Q30/2 |
LoseQCLS / S&P -66.26% / 8.12% |
No dataQCLS / S&P / 4.61% |
LoseQCLS / S&P -0.58% / 13.45% |
| 2025-Q21/2 |
LoseQCLS / S&P -64.86% / 10.94% |
No dataQCLS / S&P / 4.83% |
WinQCLS / S&P 1718.53% / 10.63% |
| 2025-Q11/2 |
LoseQCLS / S&P -69.57% / -4.27% |
No dataQCLS / S&P / 4.98% |
WinQCLS / S&P 1514.22% / 10.57% |
| 2024-Q41/2 |
LoseQCLS / S&P -29.01% / 2.41% |
No dataQCLS / S&P / 5.25% |
WinQCLS / S&P 2477.32% / 6.15% |
| 2024-Q31/2 |
LoseQCLS / S&P -11.96% / 5.89% |
No dataQCLS / S&P / 5.89% |
WinQCLS / S&P 676.95% / 6.11% |
| 2024-Q20/2 |
LoseQCLS / S&P -23.01% / 4.28% |
No dataQCLS / S&P / 5.38% |
LoseQCLS / S&P -22.51% / 5.12% |
| 2024-Q10/2 |
LoseQCLS / S&P -69.24% / 10.56% |
No dataQCLS / S&P / 5.71% |
LoseQCLS / S&P -13.88% / 5.59% |
| 2023-Q40/1 |
LoseQCLS / S&P -56.25% / 11.69% |
No dataQCLS / S&P / 6.81% |
No dataQCLS / S&P / 7.78% |
| 2023-Q30/1 |
LoseQCLS / S&P -60.53% / -3.27% |
No dataQCLS / S&P / 7.52% |
No dataQCLS / S&P / -5.03% |
| 2023-Q20/1 |
LoseQCLS / S&P -12.79% / 8.74% |
No dataQCLS / S&P / 9.50% |
No dataQCLS / S&P / -8.57% |
| 2023-Q11/1 |
WinQCLS / S&P 49.57% / 7.50% |
No dataQCLS / S&P / 10.77% |
No dataQCLS / S&P / -15.69% |
| 2022-Q40/1 |
LoseQCLS / S&P -55.94% / 7.56% |
No dataQCLS / S&P / 11.88% |
No dataQCLS / S&P / -17.99% |
| 2022-Q31/1 |
WinQCLS / S&P 20.28% / -4.88% |
No dataQCLS / S&P / 13.47% |
No dataQCLS / S&P / -1.41% |
| 2022-Q20/1 |
LoseQCLS / S&P -53.43% / -16.10% |
No dataQCLS / S&P / 13.71% |
No dataQCLS / S&P / 11.04% |
| 2022-Q10/1 |
LoseQCLS / S&P -23.10% / -4.60% |
No dataQCLS / S&P / 15.97% |
No dataQCLS / S&P / 42.23% |
| 2021-Q40/1 |
LoseQCLS / S&P -15.83% / 11.03% |
No dataQCLS / S&P / 15.00% |
No dataQCLS / S&P / 96.40% |
| 2021-Q31/1 |
WinQCLS / S&P 14.29% / 0.58% |
No dataQCLS / S&P / 10.77% |
No dataQCLS / S&P / 69.42% |
| 2021-Q20/1 |
LoseQCLS / S&P -2.17% / 8.55% |
No dataQCLS / S&P / 6.58% |
No dataQCLS / S&P / 51.81% |
| 2021-Q11/1 |
WinQCLS / S&P 61.81% / 6.17% |
No dataQCLS / S&P / -1.06% |
No dataQCLS / S&P / 7.39% |
| 2020-Q40/1 |
LoseQCLS / S&P -11.56% / 12.15% |
No dataQCLS / S&P / -3.72% |
No dataQCLS / S&P / -33.42% |
| 2020-Q30/1 |
LoseQCLS / S&P -35.34% / 8.93% |
No dataQCLS / S&P / -2.04% |
No dataQCLS / S&P / -27.10% |
| 2020-Q21/2 |
WinQCLS / S&P 63.00% / 20.54% |
LoseQCLS / S&P -54.94% / -0.46% |
No dataQCLS / S&P / -27.11% |
| 2020-Q10/2 |
LoseQCLS / S&P -33.28% / -19.60% |
LoseQCLS / S&P -32.75% / 3.47% |
No dataQCLS / S&P / -14.75% |
| 2019-Q40/2 |
LoseQCLS / S&P -69.70% / 9.07% |
LoseQCLS / S&P -5.32% / 5.36% |
No dataQCLS / S&P / 2.99% |
| 2019-Q30/2 |
LoseQCLS / S&P -2.22% / 1.70% |
LoseQCLS / S&P -23.57% / 5.02% |
No dataQCLS / S&P / 0.21% |
| 2019-Q20/2 |
LoseQCLS / S&P -53.61% / 4.30% |
LoseQCLS / S&P -21.71% / 6.64% |
No dataQCLS / S&P / 8.65% |
| 2019-Q10/2 |
LoseQCLS / S&P -14.16% / 13.65% |
LoseQCLS / S&P -33.94% / 8.12% |
No dataQCLS / S&P / 14.29% |
| 2018-Q40/2 |
LoseQCLS / S&P -50.26% / -13.52% |
LoseQCLS / S&P -49.99% / 9.05% |
No dataQCLS / S&P / 18.23% |
| 2018-Q30/2 |
LoseQCLS / S&P -26.61% / 7.71% |
LoseQCLS / S&P -23.65% / 10.21% |
No dataQCLS / S&P / 19.06% |
| 2018-Q20/2 |
LoseQCLS / S&P -53.37% / 3.43% |
LoseQCLS / S&P -18.06% / 9.03% |
No dataQCLS / S&P / 14.46% |
| 2018-Q11/2 |
WinQCLS / S&P 519.40% / -0.76% |
LoseQCLS / S&P 4.32% / 7.68% |
No dataQCLS / S&P / 12.46% |
| 2017-Q41/2 |
LoseQCLS / S&P -83.46% / 6.64% |
WinQCLS / S&P 12.49% / 7.03% |
No dataQCLS / S&P / 13.82% |
| 2017-Q31/2 |
LoseQCLS / S&P -35.20% / 4.48% |
WinQCLS / S&P 9.68% / 5.68% |
No dataQCLS / S&P / 17.57% |
| 2017-Q21/2 |
LoseQCLS / S&P -30.56% / 3.09% |
WinQCLS / S&P 27.86% / 4.83% |
No dataQCLS / S&P / 17.74% |
| 2017-Q11/2 |
LoseQCLS / S&P -5.26% / 6.07% |
WinQCLS / S&P 22.32% / 3.67% |
No dataQCLS / S&P / 13.32% |
| 2016-Q41/2 |
LoseQCLS / S&P -43.44% / 3.82% |
WinQCLS / S&P 39.99% / 2.09% |
No dataQCLS / S&P / 7.05% |
| 2016-Q31/2 |
WinQCLS / S&P 4.32% / 3.85% |
LoseQCLS / S&P -10.25% / 0.20% |
No dataQCLS / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | QCLS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -50.63% | 20.78% |
| Annualized return | -50.63% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | QCLS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.99% | 83.14% |
| Annualized return | -83.55% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | QCLS total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -76.20% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |